Tianjin Medical University Eye Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1989-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
14
Active:1
Completed:7
Trial Phases
4 Phases
Early Phase 1:1
Phase 1:2
Phase 4:2
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (50.0%)Phase 1
2 (20.0%)Phase 4
2 (20.0%)Early Phase 1
1 (10.0%)Environmental Factors and Myopia Prevalence Among Uyghur Students in Remote China
- Conditions
- MyopiaEnvironment
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-08-13
- Lead Sponsor
- Tianjin Medical University Eye Hospital
- Target Recruit Count
- 100000
- Registration Number
- NCT07119723
- Locations
- 🇨🇳
Tianjin medical university eye hospital, Tianjin, China
Aqueous Humor Proteome in Retinal Vein Occlusion With Macular Edema
Active, not recruiting
- Conditions
- Retinal Vein Occlusion
- First Posted Date
- 2025-08-06
- Last Posted Date
- 2025-08-07
- Lead Sponsor
- Tianjin Medical University Eye Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT07106268
- Locations
- 🇨🇳
Tianjin medical university eye hospital, Tianjin, province, China
Safety and Efficacy of Thermosensitive Hydroxybutyl Chitosan and 5-fluorouracil Assisted Endoscopic Dacryocystorhinostomy in the Treatment of Chronic Dacryocystitis
Phase 1
Completed
- Conditions
- DacryocystorhinostomyChronic DacryocystitisHydroxybutyl ChitosanFluorouracil
- Interventions
- First Posted Date
- 2023-12-19
- Last Posted Date
- 2023-12-19
- Lead Sponsor
- Tianjin Medical University Eye Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT06175676
- Locations
- 🇨🇳
Limin Zhu, Tianjin, China
Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients Diagnosed by Intraoperative OCT (the VIDEO Study): Study Protocol for a Randomized Controlled Trial
Phase 4
Recruiting
- Conditions
- Pars Plana VitrectomyIntraoperative Optical Coherence TomographyDiabetic Macular EdemaDexamethasone Intravitreal Implant
- Interventions
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Tianjin Medical University Eye Hospital
- Target Recruit Count
- 64
- Registration Number
- NCT05990829
- Locations
- 🇨🇳
Tianjin medical university eye hosipital, Tianjin, Tianjin, China
Analysis of Postoperative Ocular Surface Changes and Intervention Effect After PPV in MGD Dry Eye Patients
Phase 4
Completed
- Conditions
- Meibomian Gland Dysfunction of Unspecified Eye, Unspecified Eyelid
- Interventions
- Drug: Routine preoperative and postoperative anti-infection therapyDrug: artificial tear therapyProcedure: Cleaning, hot compresses and massage of the meibomian gland
- First Posted Date
- 2023-03-16
- Last Posted Date
- 2023-03-16
- Lead Sponsor
- Tianjin Medical University Eye Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT05771194
- Locations
- 🇨🇳
Tianjin medical university eye hosipital, Tianjin, Tianjin, China
- Prev
- 1
- 2
- 3
- Next
News
Intalight's DREAM OCT Platform Receives CE Mark Approval for European Market
Intalight has received CE Mark approval for its DREAM OCT platform, allowing commercialization in the European Union with advanced imaging capabilities that deliver 130-degree OCTA images.